Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
HomeTrust Bancshares
HTB
$748M
| $4.65M | ﹤0.01% |
101,668
+54,856
| +117% | +$2.65M |
2013 Q2
53 quarters
|
|
2077
Webull Corp
BULL
$2.73B
| $4.63M | ﹤0.01% |
664,888
-12,609
| -2% | -$101K |
2025 Q2
5 quarters
|
|
2078
Veracyte
VCYT
$2.03B
| $4.63M | ﹤0.01% |
100,657
+78,034
| +345% | +$3.76M |
2017 Q1
38 quarters
|
|
2079
U-Haul Holding Co
UHAL
$11B
| $4.63M | ﹤0.01% |
76,924
+33,986
| +79% | +$2.33M |
2015 Q2
45 quarters
|
|
2080
The Marzetti Company
MZTI
$3.04B
| $4.62M | ﹤0.01% |
46,623
+26,078
| +127% | +$2.84M |
2013 Q2
53 quarters
|
|
2081
Mineralys Therapeutics
MLYS
$1.43B
| $4.62M | ﹤0.01% |
184,015
+122,825
| +201% | +$3.34M |
2023 Q1
14 quarters
|
|
2082
Magnolia Oil & Gas
MGY
$6.33B
| $4.62M | ﹤0.01% |
196,817
+27,387
| +16% | +$710K |
2018 Q4
31 quarters
|
|
2083
BGC Group
BGC
$5.26B
| $4.62M | ﹤0.01% |
400,653
+81,852
| +26% | +$942K |
2013 Q2
53 quarters
|
|
2084
Intellia Therapeutics
NTLA
$1.6B
| $4.6M | ﹤0.01% |
381,781
+230,212
| +152% | +$2.88M |
2016 Q2
41 quarters
|
|
2085
Azenta
AZTA
$2.14B
| $4.6M | ﹤0.01% |
131,965
+66,787
| +102% | +$2.06M |
2013 Q2
53 quarters
|
|
2086
CALL
iShares Global Clean Energy ETF
ICLN
$2.06B
| $4.59M | ﹤0.01% |
270,000
| – | – |
2026 Q2
1 quarter
|
|
2087
StoneX
SNEX
$7B
| $4.57M | ﹤0.01% |
70,702
-295
| -0.4% | -$20.9K |
2022 Q1
18 quarters
|
|
2088
PUT
Fair Isaac
FICO
$15.6B
| $4.56M | ﹤0.01% |
+7,700
| New | +$8.43M |
2026 Q3
0 quarters
|
|
2089
Warner Music
WMG
$16.7B
| $4.56M | ﹤0.01% |
165,018
+150,591
| +1,044% | +$4.15M |
2023 Q2
13 quarters
|
|
2090
Knife River
KNF
$3.31B
| $4.55M | ﹤0.01% |
90,219
-4,238
| -4% | -$288K |
2023 Q2
13 quarters
|
|
|
DPC
2091
DPC Holdings PLC
DPC
$4.73B
| $4.55M | ﹤0.01% |
107,608
+78,408
| +269% | +$3.58M |
2026 Q2
1 quarter
|
|
2092
CALL
Voyager Technologies
VOYG
$1.84B
| $4.54M | ﹤0.01% |
150,000
| – | – |
2026 Q2
1 quarter
|
|
2093
CRISPR Therapeutics
CRSP
$4.44B
| $4.53M | ﹤0.01% |
81,954
+41,075
| +100% | +$2.22M |
2017 Q3
36 quarters
|
|
2094
Grand Canyon Education
LOPE
$3B
| $4.53M | ﹤0.01% |
29,859
+13,067
| +78% | +$1.94M |
2013 Q2
53 quarters
|
|
2095
Dolby
DLB
$6.06B
| $4.52M | ﹤0.01% |
76,993
+18,880
| +32% | +$1.09M |
2013 Q2
53 quarters
|
|
2096
JetBlue
JBLU
$1.52B
| $4.51M | ﹤0.01% |
1,066,919
+77,775
| +8% | +$402K |
2013 Q2
53 quarters
|
|
2097
Lucid Motors
LCID
$1.45B
| $4.51M | ﹤0.01% |
1,108,547
-206,616
| -16% | -$1.17M |
2022 Q1
18 quarters
|
|
2098
United Natural Foods
UNFI
$2.87B
| $4.5M | ﹤0.01% |
100,394
+58,753
| +141% | +$2.77M |
2013 Q2
53 quarters
|
|
2099
Disc Medicine
IRON
$3.97B
| $4.49M | ﹤0.01% |
68,654
+49,944
| +267% | +$3.77M |
2022 Q4
15 quarters
|
|
2100
NovoCure
NVCR
$1.4B
| $4.48M | ﹤0.01% |
280,766
+37,630
| +15% | +$628K |
2015 Q4
43 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.